Who's using GLP-1 weight loss drugs?

episode

Health Report - Separate stories podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Press Pass | Lawrence on Prep for Patriots' Run Defense, Responding & Building Trust 11 min · 23 Sep 2026 · The Jacksonville Jaguars Official Podcast Network

Iran Enters the War of Words; The AI Agenda for the Trump-Xi Summit 26 min · 23 Sep 2026 · Here's the Scoop

Trump meets Xi: what's at stake? 19 min · 23 Sep 2026 · Business Daily

THE HERD – HOUR 3 – Caleb Williams Critics “Embarrassing Yourselves” 54 min · 23 Sep 2026 · The Herd with Colin Cowherd

THE HERD – HOUR 2 – Joel Klatt: Arch Manning Needs To Play Better 1h 5m · 23 Sep 2026 · The Herd with Colin Cowherd

THE HERD – HOUR 1 – Giants Have A Jaxson Dart Dilemma | Chiefs New Offense 1h 4m · 23 Sep 2026 · The Herd with Colin Cowherd

Report any issue

Source

Recorded17 Apr 2026

Publisherabc.net.au ↗

Handlerec:18010830

Show notes

We know that growth in the use of GLP-1 drugs for diabetes and weight loss has been dramatic over the past few years.But it's hard to tell exactly how sizeable that rise has been because much of the prescribing for these drugs happens outside of the PBS, where public medication prescriptions are tracked.That's until now. New data from across New South Wales reveals how high the uptake has been, and who is using these drugs.GuestProfessor Louisa Jorm, Director of the Centre for Big Data Research in Health, University of New South WalesReferencesInitiators of Semaglutide in General Practice in New South Wales, 2020–2023: A Retrospective Cohort Study

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in